Abstract Evaluating QUADRAMET for Multiple Myeloma Presented erican Society of Hematology Annual Meeting
13th Nov 2006, 17:29 GMT
Abstract 'Phase 1 Study of Bortezomib and (153)Sm-Lexidronam Combinationfor Refractory and Relapsed Multiple Myeloma' available through ASH website
Abstract Evaluating QUADRAMET for Multiple Myeloma Presented erican Society of Hematology Annual Meeting related news:
- Abstract Evaluating QUADRAMET(R) For Multiple Myeloma To Be Presented At 2006 American Society Of Hematology (ASH) Annual Meeting — Health News from Medical News Today
- 12 Studies Evaluating Cytyc's MammoSite Radiation Therapy System Presented at ASTRO Annual Meeting — Nuclear Medicine News from StratCenter.com
- Data on PolyMedix's Novel Antibiotics Presented at the 40th Annual Meeting of the Ocular Microbiology and Immunology Group — Pharmaceuticals News from StratCenter.com
- Gastric Bypass Surgery May Lead To Increased Kidney Stone Risk — Health News from Medical News Today
- iCAD to Unveil New Product Capabilities at Radiological Society of North America Annual Meeting — Mammography News from StratCenter.com
- Shorter-course Radiation Treatment Safe For Breast Cancer — Health News from Medical News Today
- Cholesterol Screening A Cost-effective Procedure To Extend Life In Hodgkin's Disease Survivors — Health News from Medical News Today
- Radiation Heart Dose From MammoSite Compared To IMRT For Left-Sided Breast Cancers — Health News from Medical News Today
- First responders' toxic risks — Cincinnati Enquirer - Top Stories
- Outlook is positive at Microsoft's annual meeting — The Seattle Times
Latest news from Laboratory News from StratCenter.com:
- QIAGEN Introduces Novel Technology for Customized RNAi Assay Products
- Stratagene Reports Q3 Results
- Viking Systems Appoints Dr Michael Manyak to Its Board
- Soliant Health To Exhibit at the American Speech-Language-Hearing Assoc Conference
- Sysmex America Awarded Contract to Service VA Med Cntrs in Midwest States
- Ronald D Luff, MD, Recognized By the American Society of Cytopathology for Groundbreaking Work in Diagnosis of Cervical Disease
- INNOVIVE Pharmaceuticals Reports Q3 Results
- Launch of 'Egg Banking' Program Breaks New Ground as 1st Program of Its Kind in NC
- Global Care Quest Announces ICIS 5
- Portola Pharmaceuticals Presents Data Associated With Its Novel Anticoagulation Assay at American Heart Assoc Scientific Sessions